Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C••••• I•••••••••

G••••• P•••• Capital Completes Acquisition of C••••• I•••••••••, Inc. Tue, 11/27/2018 - 18:05

Platform acquisitionclosedannounced Nov 27, 2018closed Nov 27, 2018Fact
What happened
Target
C••••• I•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • C••••••••• V•••••••••Deal partnerconfirmed
    ““We are excited to begin our collaboration with the C••••• leadership team to bring Corplex Donepezil, a life-changing drug and novel technology, to patients with Alzheimer’s disease as soon as possible,” said C••••••••• V•••••••••, Managing Partner at G••••• P•••• Capital.”
  • G••••• P•••• C••••••• L••Sponsorconfirmed
    “G••••• P•••• Capital (“G••••• P••••”), a private investment firm focused on the healthcare and life sciences sectors, announced today that it has completed the previously announced tender offer for all outstanding shares of common stock of C••••• I•••••••••, Inc. (Nasdaq:CORI) (“C•••••”), a commerci”
Side not stated
Evidence
“G••••• P•••• Capital Completes Acquisition of C••••• I•••••••••, Inc. Tue, 11/27/2018 - 18:05”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
G••••• P•••• Capital Completes Acquisition of C••••• I•••••••••, Inc. Tue, 11/27/2018 - 18 | Private Equity Intelligence | DFX